Ropes & Gray Names 9 New Partners in Six Offices Worldwide
Global law firm Ropes & Gray proudly announces that 9 attorneys have been named partners of the firm, effective November 1. In addition, the firm promoted six associates to counsel.
Clients across a variety of key global industries, including technology, asset management, life sciences and health care, will benefit from the newly promoted partners’ diverse knowledge and experience. The new partners represent six of the firm’s offices and a variety of its leading practices, including private equity, securities & public companies, mergers & acquisitions, private investment funds, life sciences, finance, intellectual property, health care, tax, real estate and business restructuring.
“We’re delighted to recognize the outstanding legal skills and commitment to client service demonstrated by these bright and accomplished attorneys,” said firm chairman Brad Malt. “Their addition to Ropes & Gray’s partnership strengthens the firm for the future and helps ensure our continued success.”
Meet Ropes & Gray’s newest partners:
Megan Baca (Silicon Valley) advises major life sciences, technology, branded products, retail, and financial services companies in strategic transactions where technology or intellectual property assets are key drivers. Ms. Baca, a certified privacy professional, also counsels clients in a broad range of digital health, social media, advertising, and data privacy and security matters.
Zachary Blume (Boston) represents public companies and investment banks in business combinations and capital markets transactions. In addition, Mr. Blume regularly advises clients on securities law compliance and corporate governance issues.
Charles Boer (Boston) advises private equity firms and strategic investors in the structuring and negotiation of leveraged buyouts, public and private mergers, acquisitions and divestitures, and other general corporate matters. Mr. Boer also has experience negotiating partnership and joint venture transactions across a wide range of industries, including consumer goods and technology.
Kellie Combs (Washington, D.C.) provides legal and strategic advice to pharmaceutical, biotechnology and medical device manufacturers on a broad range of regulatory, enforcement and transactional matters. Ms. Combs has extensive experience handling matters implicating FDA promotional rules and the First Amendment and routinely advises clients on lifecycle management, regulation of clinical research, and post-approval compliance.
Andrew Devore (Boston) represents lenders, bondholders, private equity funds, portfolio companies, and creditors committees in bankruptcy- and insolvency-related litigation at both the trial and appellate levels. Mr. Devore also has experience representing debtors and creditors committees in chapter 11 cases and out-of-court restructurings, and advising purchasers in bankruptcy sale asset acquisitions.
Andrew Howard (London) handles a wide spectrum of complex UK tax issues, focusing on all types of transactions involving investment funds, including private equity, finance, securitization, special situations, real estate and fund formation. Mr. Howard also counsels clients on cross-border and international tax matters.
Vincent Ip (Hong Kong) represents institutional and other investors in connection with investments in private equity funds, hedge funds and separate accounts, as well as co-investment and secondary transactions. Mr. Ip also has extensive experience advising fund sponsors on all aspects of their business, including the formation and ongoing representation of Asia-focused private investment funds.
Patricia Lynch (Boston) advises clients on a wide range of structured finance and fund financing transactions, including collateralized loan obligations (CLOs), whole business securitizations, receivables-backed variable funding note facilities, capital call facilities and credit fund leverage facilities. Ms. Lynch also works with corporate borrowers on large cap and middle-market financing transactions, including syndicated credit facilities, ABL facilities and high yield bond issuances.
David Seymour (London) represents investors and lenders on a variety of real estate transactions across the risk spectrum, including joint ventures, co-investments, direct and indirect acquisitions/disposals, sale and leasebacks, development projects, leasing, outsourcing, and financings. Mr. Seymour advises on all types of distressed and non-distressed assets, including major offices, hotels, stadia, airports, hospitals, and retail, leisure and industrial assets.
Meet our new counsel:
James L. Davis, Jr. (Silicon Valley) litigates intellectual property disputes in federal courts, at the International Trade Commission, and at the Patent Trial and Appeal Board, and advises clients concerning intellectual property strategies, due diligence and licensing. Mr. Davis leverages his background in electrical and computer engineering to represent clients across a wide range of technologies, including semiconductors, analog circuits, wireless technology, consumer electronics, internet services and medical devices.
Andrew Radsch (Silicon Valley) represents U.S. and international clients in patent litigation in federal courts and at the International Trade Commission, and he regularly advises companies on offensive and defensive pre-litigation strategies. Mr. Radsch’s clients span a range of industries and technologies, including computer software and hardware, consumer electronics, wireless communications, semiconductor manufacturing, pharmaceuticals, medical devices and consumer care products.
Alexander Robb (London) has broad experience in both UK and international acquisition financing, restructuring and corporate refinancing. Mr. Robb has advised investment banks, commercial banks, private equity sponsors and publicly listed companies on transactions in sectors ranging from infrastructure to hospitality and telecommunications.
David Zhang (Shanghai) advises clients on internal investigations, due diligence and compliance programs, with a focus on anti-corruption and anti-bribery matters in China. Mr. Zhang has conducted investigations for and advised multinational and U.S.-listed clients across a wide range of industries, including life sciences, venture capital/private equity, internet and technology, hospitality, food and beverage, and aerospace and aviation.